These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7799893)

  • 1. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
    Colantonio D; Casale R; Pasqualetti P
    Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
    Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
    Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
    Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
    Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
    Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT
    Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1996; 18(4):137-41. PubMed ID: 9177611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
    Burghardt W; Wernze H; Diehl KL
    Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
    Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
    Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: circadian study.
    Colantonio D; Pasqualetti P; Casale R; Desiati P; Giandomenico G; Natali G
    Life Sci; 1989; 45(7):631-5. PubMed ID: 2528047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis.
    Tulassay T; Tulassay Z; Rascher W
    Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurohumoral activity in liver cirrhosis].
    Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
    Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
    Pidlich J; Müller C; Hartter E; Renner F; Klepetko W; Miholic J; Woloszczuk W
    Acta Med Austriaca; 1987; 14(5):125-9. PubMed ID: 2964160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
    Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J
    Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.